BSE filing, NSE: ZYDUSLIFE. Summary written from the filing by ALFA Finder's alert engine.
Zydus Lifesciences Ltd: key numbers
- Share price
- ₹1,245.50
- Market cap
- ₹1,25,326 Cr
- Revenue (annual)
- ₹27,148 Cr
- Net profit (annual)
- ₹5,040 Cr
- P/E (TTM)
- 27.8×Sector 45.9×
- Promoter holding
- 75.01%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Lifesciences Ltd
All →Zydus Lifesciences Management Change
Zydus Lifesciences announced the resignation of Dr. Amrut Naik, President of International Markets, effective 7 November 2026. Mr. Christoph Stoller has been appointed to the same senior management role from 2 November 2026.
Zydus Lifesciences Partnership
Zydus Lifesciences' division Zylidac Bio partnered with Prolific Machines to scale their next-generation biologics manufacturing platform for GMP production.
Zydus Lifesciences Regulatory Approval
Zydus Lifesciences received USFDA approval for its Estradiol-Levonorgestrel Transdermal System ANDA, designated as a CGT. The product is eligible for 180-day exclusivity upon first commercial marketing.
Zydus Lifesciences Board Meeting Date
Zydus Lifesciences intimated a board meeting on 4 Nov 2026 to approve unaudited Q1/H1 FY27 results. Trading window remains closed until 6 Nov 2026.
Zydus Lifesciences Other Announcement
Zydus Lifesciences Limited has been assigned an ESG rating of 71 by NSRAL for the financial year 2026. This unsolicited rating reflects the company's sustainability performance.
Zydus Lifesciences Capacity Expansion: ₹190 Cr Investment
Zydus' JV with Sunshine Healthcare signed a BOI agreement to establish a pharma plant in Sri Lanka. Investment exceeds USD 20 million (~₹190 Cr), targeting 2028.
- Value
- ₹190.0 Cr
Other annual report announcements
All →Garment Mantra Lifestyle Annual Report
Garment Mantra Lifestyle submitted a revised FY2025-26 Annual Report correcting five observations, including related-party transaction labels and auditor location. No financial event or new business activity is reported.
Inani Securities Annual Report
Inani Securities submitted its 32nd Annual Report for FY 2025-26 with the AGM notice, AGM set for 23 September 2026. The filing is the full annual report and cover letter.
Datakosa Annual Report
Bodhtree Consulting filed its 44th Annual Report for FY 2025-26 with the AGM notice for September 9, 2026. It reports no new transaction or financial event.
Morarka Finance Annual Report
Morarka Finance filed its 2025-26 Annual Report and AGM notice for the July 15, 2026 meeting. Agenda includes Pranay Morarka's Managing Director appointment and remuneration.
Venlon Enterprises Annual Report
Venlon Enterprises filed its 2025-26 Annual Report ahead of its September 18, 2026 AGM. The notice seeks approval for three related-party transactions.
Gujarat Peanut and Agri Products Annual Report
Gujarat Peanut And Agri Products filed a resubmitted Annual Report for FY 2025-26 after an earlier filing went under the wrong module. The report shows turnover of Rs. 38,932.71 Lakhs and PAT of Rs. 738.30 Lakhs.